Safety and tolerability of lersivirine, a nonnucleoside reverse transcriptase inhibitor, during a 28-day, randomized, placebo-controlled, Phase I clinical study in healthy male volunteers-Reference-Cited by-同舟云学术

Safety and tolerability of lersivirine, a nonnucleoside reverse transcriptase inhibitor, during a 28-day, randomized, placebo-controlled, Phase I clinical study in healthy male volunteers

Published:2010-10 Issue:11 Volume:32 Page:1889-1895
ISSN:0149-2918
Container-title:Clinical Therapeutics
language:en
Short-container-title:Clinical Therapeutics

Author:

Davis John,Hackman Frances,Ndongo Marie-Noella,Choo HengWee,Lewis Drew,Tawadrous Margaret,Goodrich James,Langdon Grant

Publisher

Elsevier BV

Subject

Pharmacology (medical),Pharmacology

Reference13 articles.

1. Antiretroviral treatment of adult HIV infection: 2008 Recommendations of the International AIDS Society-USA panel;Hammer;JAMA.,2008

2. Efficacy and safety ofTMC125 (etravirine) in treatment-experienced HIV-1-infected patients in DUET-1: 24-Week results from a randomised, double-blind, placebo- controlled trial;Madruga;Lancet.,2007

3. Efficacy and safety of etravirine in treatment-experienced, HIV-1 patients: Pooled 48 week analysis of two randomized, controlled trials;Katlama;AIDS.,2009

4. International perspectives on antiretroviral resistance. Nonnucleoside reverse transcriptase inhibitor resistance;Deeks;J Acquir Immune Defic Syndr.,2001

Cited by 7 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Investigational reverse transcriptase inhibitors for the treatment of HIV;Expert Opinion on Investigational Drugs;2015-06-19

2. Efficacy and Safety of Lersivirine Versus Etravirine for the Treatment of HIV-1 Infection in Patients with Prior Non-Nucleoside Reverse Transcriptase Inhibitor (NNRTI) Use and Evidence of NNRTI Resistance: A Randomized Phase 2B Trial;HIV Clinical Trials;2014-10

3. Lersivirine – a new drug for HIV infection therapy;Expert Opinion on Investigational Drugs;2013-10-16

4. Developmental Toxicity of Lersivirine in Rabbits when Administered throughout Organogenesis and when Limited to Sensitive Windows of Axial Skeletal Development;Birth Defects Research Part B: Developmental and Reproductive Toxicology;2012-04-11

5. Effects of ketoconazole and valproic acid on the pharmacokinetics of the next generation NNRTI, lersivirine (UK-453,061), in healthy adult subjects;British Journal of Clinical Pharmacology;2012-04-05